BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10507577)

  • 1. Policy options to reduce tobacco-caused mortality.
    Sweanor DT
    J Addict Dis; 1999; 18(3):1-11. PubMed ID: 10507577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a comprehensive long term nicotine policy.
    Gray N; Henningfield JE; Benowitz NL; Connolly GN; Dresler C; Fagerstrom K; Jarvis MJ; Boyle P
    Tob Control; 2005 Jun; 14(3):161-5. PubMed ID: 15923465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the insidious health and financial burden of tobacco use in Missouri: the role of medical and public health professionals.
    Everett KD; Bullock L; Longo DR
    Mo Med; 2006; 103(2):175-9. PubMed ID: 16703720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco harm reduction: how rational public policy could transform a pandemic.
    Sweanor D; Alcabes P; Drucker E
    Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing tobacco harm: research challenges and issues.
    Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trends in international tobacco control.
    Thompson F; Fagerström K
    Clin Occup Environ Med; 2006; 5(1):101-16, ix. PubMed ID: 16446257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE; Zeller M
    Handb Exp Pharmacol; 2009; (192):511-34. PubMed ID: 19184661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on the role of the Society for Research on Nicotine and Tobacco in promoting global tobacco research and reducing tobacco harm.
    Lando HA; Borrelli B; Muramoto ML; Ward KD
    Nicotine Tob Res; 2006 Dec; 8(6):761-5. PubMed ID: 17132523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supping with the devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products.
    Hall W; Gartner C
    Public Health; 2009 Mar; 123(3):287-91. PubMed ID: 19223052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What should be the elements of any settlement with the tobacco industry?
    Burns D; Benowitz N; N'Connolly GN; Cummings KM; Davis RM; Henningfield JE; Shopland DR; Warner KE
    Tob Control; 1997; 6(1):1-4. PubMed ID: 9176975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the 2006 Scottish smoke-free legislation on sales of nicotine replacement therapy.
    Lewis SA; Haw SJ; McNeill A
    Nicotine Tob Res; 2008 Dec; 10(12):1789-92. PubMed ID: 19023830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Political economy of tobacco control policy on public health in Japan.
    Desapriya EB; Iwase N; Shimizu S
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):15-33. PubMed ID: 12687722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.